p Chief Scientific Officer (CSO) /p p Cardiff, UK | Relocation Support Visa Sponsorship Available /p p Build the scientific direction of a next-generation AI-enabled biotech. /p p br /p p Antiverse is looking for a Chief Scientific Officer to help shape the next chapter of the company. This is a rare opportunity to join an AI-driven antibody discovery business at a pivotal stage of growth and determine not only which programmes move forward, but what the company becomes over the next decade. /p p br /p p Were looking for a scientific leader who can combine deep disease biology expertise with exceptional strategic judgement, helping to connect biology, technology, AI and therapeutics into a differentiated platform and pipeline. /p p br /p p About Antiverse /p p Antiverse is an AI-driven biotech company developing antibodies against some of the most difficult targets in medicine, including GPCRs and ion channels. /p p By combining machine learning, advanced cell engineering, antibody discovery and high-throughput biology, the company is building a platform designed to create therapeutics that were previously difficult or impossible to discover. /p p The next phase of growth is not simply about discovering more antibodies. /p p Its about building a world-class, disease-informed platform capable of repeatedly generating better therapeutic opportunities. /p p br /p p Current areas of focus include: /p ul li Idiopathic Pulmonary Fibrosis (IPF) /li li MASH / metabolic disease /li li Inflammatory diseases /li li Complex biologics and antibody therapeutics /li /ul p br /p p The Opportunity /p p You will work directly with the CEO, leadership team, board, investors and scientific teams to determine: /p ul li Which disease areas Antiverse should prioritise /li li Which targets deserve investment /li li Which datasets should be generated /li li Which biological systems should be built /li li How experimental biology and AI should work together /li li How the platform evolves over time /li li How programmes are progressed from hypothesis to partner-ready assets /li /ul p br /p p This role is as much about scientific judgement as it is scientific expertise. /p p What Youll Be Responsible For /p ul li Defining Antiverses scientific strategy and long-term direction /li li Building and evolving therapeutic area strategy /li li Advancing programmes within IPF and MASH /li li Leading target identification and prioritisation activities /li li Developing disease-informed platform strategy /li li Guiding translational biology and pharmacology efforts /li li Defining in vitro and in vivo validation strategies /li li Working closely with AI and machine learning teams to shape dataset generation /li li Leading progression of antibody programmes from discovery through preclinical development /li li Supporting partnering, licensing and external collaborations /li li Acting as a key scientific representative for investors, pharmaceutical partners and advisors /li li Building and mentoring a high-performing scientific organisation /li /ul p br /p p What Were Looking For /p p Essential /p ul li Significant scientific leadership experience within biotech or pharmaceutical drug discovery /li li Deep expertise in IPF, MASH, fibrosis, metabolic disease, inflammation or closely related biology /li li Strong biologics and/or antibody discovery background /li li Experience progressing programmes through discovery and preclinical development /li li Strong translational biology expertise /li li Experience leading multidisciplinary scientific teams /li li Track record of portfolio, target selection and programme prioritisation decisions /li li Ability to communicate complex science to investors, boards and external partners /li li Strategic mindset with the ability to connect science and commercial impact /li /ul p br /p p Highly Desirable /p ul li Previous CSO or senior executive scientific leadership experience /li li GPCR biology expertise /li li Ion channel biology expertise /li li AI-enabled drug discovery experience /li li TechBio experience /li li Fundraising exposure /li li Licensing and partnering experience /li li Experience building platform companies rather than individual therapeutic programmes /li /ul p br /p p Who Will Thrive Here? /p p Youll likely be a fit if you: /p ul li Think beyond individual assets and programmes /li li Enjoy connecting disease biology, technology and therapeutic strategy /li li Are comfortable making difficult portfolio decisions /li li Can operate at both scientific and executive level /li li Are excited by ambiguity and company-building /li li Want genuine influence over the future direction of a business /li li Are motivated by building something rather than maintaining it /li /ul p br /p p Package /p ul li Competitive base salary /li li Meaningful stock option package /li li Private medical insurance /li li Flexible working hours /li li Relocation support /li li Visa sponsorship available for exceptional candidates /li li Modern office and laboratory facilities /li li Equipment allowance /li li 25 days annual leave plus public holidays /li li Additional Summer Fridays /li /ul p br /p p For a confidential discussion, please get in touch. /p
Read Less
